Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vericiguat effect on vascular function in HFrEF
NCT05420012Phase 4Completed
- Start
- May 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vericiguat in heart failure with reduced ejection fraction (HFrEF). Started May 2023; status: completed.
02
Drugs
vericiguat
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT05420012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05420012.